The Effect of Market Valuation Ratio and Company Value on Investor Reactions During the Pandemic in Pharmaceutical and Health Companies Listed on the Indonesian Stock Exchange Period 2020-2021

Read full text Summarise with VIRAT
Authors: Corneles Tuhilatu, Puji Harto
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

During the COVID-19 pandemic, stock valuation through a fundamental analysis approach is an important factor to avoid losses and investor pessimism in investing in the Indonesian capital market. So this study aims to determine the influence between Market Valuation Ratio (PER) and Company Value (PBV) on Investor Reaction (TVA) in the capital market during the covid19 pandemic. The method used in this study is a quantitative method with secondary data types and the sampling technique used is purposive sampling. Pharmaceutical and Health Companies are the population of this study which found 43 companies listed on the Indonesia Stock Exchange and 36 samples from the observation period during the 2020-2021 period. The results of this study indicate that during the COVID-19 pandemic from 2020-2021, there is no influence between the Market Valuation Ratio (PER) and Firm Value (PBV) on Investor Reaction (TVA) in the Indonesian capital market.

Fields of Study & Subjects

Financial Analysis and Corporate Governance Financial Markets and Investment Strategies Financial Reporting and Valuation Research

Publication details

Journal / source
Journal of Economics Finance and Management Studies
Volume
09
Issue
03
Pages
1492–1505
Publication date
25 March 2026
Language
EN